Table 4.
Changes in health outcomes at follow-up compared to baseline for participants who reached follow-up.
| Health outcomes and measures | Total (n=100) | P value | Completes (n=83) | P value | |
| HbA1ca change |
|
|
|
|
|
|
|
Percentage point change in HbA1c, mean (95% CI) | –1.1 (–1.4 to –0.7) | <.001 | –1.3 (–1.7 to –0.8) | <.001 |
|
|
Participants with ≥1 percentage point reduction, n (%) | 49 (49) |
|
49 (59) |
|
| Weight change |
|
|
|
|
|
|
|
Weight change expressed as a percentage of baseline weight (%), mean (95% CI) | –2.0 (–2.8 to –1.2) | <.001 | –2.3 (–3.3 to –1.4) | <.001 |
|
|
Participants with loss of ≥5% of initial baseline weight, n (%) | 17 (17) |
|
17 (21) |
|
aHbA1c: glycated hemoglobin.